Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 10;44(1):376.
doi: 10.1007/s10792-024-03289-1.

Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series

Raul E Ruiz-Lozano  1   2 , Hazem M Mousa  1 , Matias Soifer  1   2 , Nadim S Azar  1 , Manuel E Quiroga-Garza  1   2 , Daliya Dzhaber  1 , Sofia Murillo  1   3 , Ailin Song  1 , C Egla Rabinovich  1   4 , Victor L Perez  5   6   7
Affiliations

Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series

Raul E Ruiz-Lozano et al. Int Ophthalmol. .

Abstract

Purpose: Evaluate the response to adalimumab (ADA) in pediatric chronic anterior uveitis (pCAU).

Methods: Retrospective chart review of pCAU patients treated with ADA. Outcomes evaluated included the proportion of patients achieving zero ocular inflammation and discontinuation of topical corticosteroids, visual outcomes, and incidence of uveitis recurrences after ≥ 12 months of prescribing ADA. Incidence and risk factors for developing anti-adalimumab antibodies (AAAs) were also evaluated.

Results: Of 27 children aged 11 years, 16 (59%) were Caucasian and 6 (22%) African Americans. Thirteen (48%) patients had idiopathic pCAU, 12 (44%) had juvenile idiopathic arthritis (JIA) related pCAU, and 2 (7%) had tubulointerstitial nephritis and uveitis syndrome. At baseline, African American children had worse visual acuity (p = 0.026). At 1 year, 21 (78%) children achieved zero ocular inflammation (remission). Risk factors associated with non-remission were being African American (20% vs. 94%, p = 0.003) and experiencing ≥ 1 episode of uveitis recurrence (100% vs. 0%, p < 0.001). Six episodes of uveitis recurrence were documented in five children, four of whom were African American. Topical corticosteroids were discontinued in 83% of children, and visual acuity remained stable for 1 year. Twelve children were tested for AAAs due to arthritis or uveitis flare-ups, with five (42%) being positive. No significant factors were associated with the development of AAAs.

Conclusions: We found that ADA is effective in controlling inflammation, reducing the need for topical corticosteroids, and maintaining visual acuity in pCAU. There appears to be racial differences in African American children who had worse baseline disease and poorer outcomes. Studies are necessary to understand better and address these disparities.

Keywords: Adalimumab; Anti-adalimumab antibodies; Chronic anterior uveitis; Juvenile idiopathic arthritis; Pediatric uveitis; Uveitis recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Rabinovich CE (2011) Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update. Curr Opin Rheumatol 23:432–436. 10.1097/BOR.0b013e328349c324 - PubMed
    1. Angeles-Han ST, Rabinovich CE (2016) Uveitis in children. Curr Opin Rheumatol 28:544–549. 10.1097/BOR.0000000000000316 - PMC - PubMed
    1. Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J (2019) 2019 American college of rheumatology/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken) 71:703–716. 10.1002/acr.23871 - PMC - PubMed
    1. Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS (2006) Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology 113:1874–1877. 10.1016/j.ophtha.2006.05.016 - PubMed
    1. Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143:840–846. 10.1016/j.ajo.2007.01.033 - PubMed

LinkOut - more resources